Gilead’s COVID-19 antiviral remdesivir gets conditional EU clearance

Click For Larger Image & Read More
Gilead’s COVID-19 antiviral remdesivir gets...
 © In-Cyprus 2020
The European Commission said on Friday it had given conditional approval for the use of antiviral  remdesivir  in severe COVID-19 patients following an accelerated review process, making it the region’s first therapy to be authorised to treat the virus.

The move comes just a week after the European Medicines Agency (EMA) gave its go-ahead for the drug produced by Gilead Sciences to be use in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support.

It also comes just days after the company allocated nearly all of...


Read all latest: Cyprus Coronavirus News Updates - Live

This article was automatically added to our system 3-7-2020

Gilead’s COVID-19 antiviral remdesivir gets conditional EU clearance


The contents of this article including any associated images are © In-Cyprus 2020
Views & opinions expressed in this article are those of the author and/or In-Cyprus .

Advertise Here

  Trending Cyprus News

Advertise Here

Article Tags: gilead, covid, antiviral, remdesivir, conditional, clearance,